On January 31, 2020, international health authorities and experts leveled criticism at China for what they described as a lack of accurate information and prompt action during the early stages of the 2019-novel coronavirus outbreak. The criticism centered on Chinese scientists’ decision to publish the virus’s genome sequence in early January 2020 without simultaneously providing a physical sample to the World Health Organization. This omission, according to global health officials, impeded worldwide efforts to curb the spread of a pathogen that has since infected thousands and resulted in hundreds of fatalities.
The absence of a live virus sample delayed the global scientific community’s ability to develop and verify diagnostic tests. Dr. Julian Druce, who leads the virus identification laboratory at Australia’s Doherty Institute, emphasized the importance of having the actual pathogen. “Having the real virus means we now have the ability to actually validate and verify all test methods, and compare their sensitivities and specificities,” he stated. His team in Melbourne successfully cultured the virus from a sample obtained from an infected patient, a breakthrough that occurred only after China’s delay in sharing its own sample.
Social media users and critics expressed disappointment with Beijing’s handling of the crisis, with some accusing the government of allowing the virus to spread rather than implementing aggressive containment measures. This criticism parallels earlier failures during the SARS outbreak in the early 2000s, a crisis that killed nearly 800 people. During that period, Chinese journalists and intellectuals pressured the government into adopting greater transparency.
Questions have also emerged regarding China’s motives. Unverified patent documents circulating online suggest that Chinese experts may have been aware of the virus for several years. The Washington Times reported unsubstantiated claims that the lethal animal virus epidemic may have originated in a Wuhan laboratory connected to China’s covert biological weapons program. These allegations remain unconfirmed but have contributed to growing distrust. The Chinese government has not directly addressed these claims, instead focusing on domestic containment efforts and public messaging.
In contrast to China’s approach, Australian scientists acted swiftly. The Doherty Institute’s successful replication of the virus represents a significant advancement for diagnosis and vaccine development. The cultured virus can serve as control material for testing, enabling laboratories worldwide to validate their methods. The Australian team committed to sharing their discovery with the World Health Organization and other nations, a level of transparency that starkly contrasts with China’s initial response.
The coronavirus outbreak has highlighted the dangers of information control during a health emergency. When critical data is withheld, the entire global community suffers. The World Health Organization has consistently urged full cooperation from all countries during health crises. China’s failure to share the virus sample promptly has undermined international trust and allowed the pathogen to spread across borders. With the Australian breakthrough, scientists now have a path forward for developing better tests and vaccines, but the consequences of China’s delay are already evident in the virus’s spread to multiple countries and the rising death toll.
